electroCore (ECOR) Income from Non-Controlling Interests (2017 - 2018)
electroCore's quarterly Income from Non-Controlling Interests came in at $55005.0 in Q1 2018, up 123.89% quarter-over-quarter from -$230218.0 in Q4 2017.
electroCore has reported Income from Non-Controlling Interests for 2 years, with the latest figure at $55005.0 in Q1 2018.
- For the quarter ending Q1 2018, Income from Non-Controlling Interests changed N/A year-over-year to $55005.0; the trailing twelve-month figure through Dec 2018 stood at $55005.0 (changed N/A YoY), and the FY2018 full-year result was $55005.0, up 123.27% from the prior year.
- Income from Non-Controlling Interests for Q1 2018 stood at $55005.0, up from -$230218.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $55005.0 in Q1 2018, with the low at -$230218.0 in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 100,000.00 |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 55,005.00 |
| Dec 31, 2017 | -230,218.00 |
| Sep 30, 2017 | -95.00 |
| Jun 30, 2017 | -6,045.00 |